Tang SS - Search Results

1

Treatment of hypertension and dyslipidemia or their combination among US managed-care patients.

Dutro MP, Gerthoffer TD, Peterson ED, Tang SS, Goldberg GA. Dutro MP, et al. Among authors: tang ss. J Clin Hypertens (Greenwich). 2007 Sep;9(9):684-91. doi: 10.1111/j.1524-6175.2007.07146.x. J Clin Hypertens (Greenwich). 2007. PMID: 17786069 Free PMC article.

2

Exploring the methodological challenges of investigating comparison groups with different underlying characteristics: a case study.

Arocho R, Solis A, Wade S, Goldberg G, Tang S. Arocho R, et al. J Manag Care Pharm. 2002 Sep-Oct;8(5):353-9. doi: 10.18553/jmcp.2002.8.5.353. J Manag Care Pharm. 2002. PMID: 14613401

3

Regional differences in the prevalence, treatment and control of hypertension and dyslipidemia in US urban Hispanic populations participating in health screening events.

Lee E, Candrilli SD, Roberts CS, Tang SS, Bassin S, Wong ND. Lee E, et al. Among authors: tang ss. Ethn Dis. 2008 Autumn;18(4):409-14. Ethn Dis. 2008. PMID: 19157243

4

Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens.

Bisognano J, McLaughlin T, Roberts CS, Battleman D, Schwartz B, Garza D, Tang S. Bisognano J, et al. Am J Hypertens. 2004 Aug;17(8):676-83. doi: 10.1016/j.amjhyper.2004.04.007. Am J Hypertens. 2004. PMID: 15323063

5

Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension.

Lopez VA, Franklin SS, Tang S, Wong ND. Lopez VA, et al. Among authors: tang s. J Clin Hypertens (Greenwich). 2007 Jun;9(6):436-43. doi: 10.1111/j.1524-6175.2007.06518.x. J Clin Hypertens (Greenwich). 2007. PMID: 17541329 Free PMC article.

6

Racial disparities in hypertension control, but not treatment intensification.

Umscheid CA, Gross R, Weiner MG, Hollenbeak CS, Tang SS, Turner BJ. Umscheid CA, et al. Among authors: tang ss. Am J Hypertens. 2010 Jan;23(1):54-61. doi: 10.1038/ajh.2009.201. Epub 2009 Nov 5. Am J Hypertens. 2010. PMID: 19893494

7

Treatment and control of BP and lipids in patients with hypertension and additional risk factors.

Welch V, Tang SS. Welch V, et al. Among authors: tang ss. Am J Cardiovasc Drugs. 2007;7(5):381-9. doi: 10.2165/00129784-200707050-00008. Am J Cardiovasc Drugs. 2007. PMID: 17953476

8

Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States.

Wong ND, Lopez V, Tang S, Williams GR. Wong ND, et al. Am J Cardiol. 2006 Jul 15;98(2):204-8. doi: 10.1016/j.amjcard.2006.01.079. Epub 2006 May 11. Am J Cardiol. 2006. PMID: 16828593

9

Effect of patient comorbidities on filling of antihypertensive prescriptions.

Lagu T, Weiner MG, Eachus S, Tang SS, Schwartz JS, Turner BJ. Lagu T, et al. Among authors: tang ss. Am J Manag Care. 2009 Jan;15(1):24-30. Am J Manag Care. 2009. PMID: 19146361 Free article.

10

Does synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy?

Agarwal S, Tang SS, Rosenberg N, Pettitt D, McLaughlin T, Joyce A, Schwartz JS. Agarwal S, et al. Among authors: tang ss. Am J Ther. 2009 Mar-Apr;16(2):119-26. doi: 10.1097/MJT.0b013e31816b69bc. Am J Ther. 2009. PMID: 19114872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters